False-positive Mycobacterium tuberculosis cultures in 44 laboratories in The Netherlands (1993 to 2000): Incidence, risk factors, and consequences

Journal of Clinical Microbiology

Volumn 40, Issue 11, 2002, Pages 4004-4009

  De Boer, Annette S ^a   Blommerde, Barbara ^a   De Haas, Petra E W ^a   Sebek, Maruschka M G G ^a   Lambregts van Weezenbeek, Kitty S B ^a   Dessens, Mirjam ^a   Van Soolingen, Dick ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DNA FINGERPRINTING; HEALTH CARE QUALITY; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; NETHERLANDS; NONHUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; TUBERCULOSIS;

BACTERIOLOGICAL TECHNIQUES; CULTURE MEDIA; FALSE POSITIVE REACTIONS; HUMANS; INCIDENCE; LABORATORIES; MYCOBACTERIUM TUBERCULOSIS; NETHERLANDS; RISK FACTORS; TUBERCULOSIS, PULMONARY;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0036840822     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.11.4004-4009.2002     Document Type: Article

References (27)

1. Agerton, T., S. Valway, B. Gore, C. Pozsik, B. Plikaytis, C. Woodley, and I. Onorato. 1997. Transmission of a highly drug-resistant strain (strain Wl) of Mycobacterium tuberculosis. Community outbreak and nosocomial transmission via a contaminated hronchoscope. JAMA 278:1073-1077.
2. Bauer, J., V. O. Thomsen, S. Poulsen, and A. B. Andersen. 1997. False-positive results from cultures of Mycobacterium tuberculosis due to laboratory cross-contamination confirmed by restriction fragment length polymorphism. J. Clin. Microbiol. 35:988-991.
3. Braden, C. R., G. L. Templeton, W. W. Stead, J. H. Bates, M. D. Cave, and S. E. Valway. 1997. Retrospective detection of laboratory cross-contamination of Mycobacterium tuberculosis cultures with use of DNA fingerprint analysis. Clin. Infect. Dis. 24:35-40.
4. Burman, W. J., and R. R. Reves. 2000. Review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment. Clin. Infect. Dis. 31:1390-1395.
5. Burman, W. J., B. L. Stone, R. R. Reves, M. L. Wilson, Z. Yang, H. El-Hajj, J. H. Bates, and M. D. Cave, 1997. The incidence of false-positive cultures for Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 155:321-326.
6. Centers for Disease Control and Prevention. 2000. Misdiagnoses of tuberculosis resulting from laboratory cross-contamination of Mycobacterium tuberculosis cultures - New Jersey, 1998. Morb. Mortal. Wkly. Rep. 49:413-416.
7. Das, S., S. L. Chan, B. W. Allen, D. A. Mitchison, and D, B. Lowrie. 1993. Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy. Tuber. Lung Dis. 74:47-51.
8. Douglas, J. G., and M. J. McLeod, 1999. Pharmacokinetic factors in the modern drug treatment of tuberculosis. Clin. Pharmacokinet. 37:127-146.
9. Dunlap, N. E., R. H. Harris, W. H. Benjamin, Jr., J. W. Harden, and D. Hafner. 1995. Laboratory contamination of Mycobacterium tuberculosis cultures. Am. J. Respir. Crit. Care Med. 152:1702-1704.
10. Fryatt, R. J, 1997. Review of published cost-effectiveness studies on tuberculosis treatment programmes. Int. J. Tuberc. Lung Dis.1:101-109.
11. Gascoyne-Binzi, D. M., R. E. Barlow, R. Frothingham, G. Robinson, T. A. Collyns, R. Gelletlie, and P. M. Hawkey. 2001. Rapid identification of laboratory contamination with Mycobacterium tuberculosis using variable number tandem repeat analysis. J. Clin. Microbiol. 39:69-74.
12. Grange, J. M., P. A. Winstanley, and P. D. Davies. 1994. Clinically significant drug interactions with antituberculosis agents. Drug Safety 11:242-251.
13. Griffiths, P. A., J. R. Babb, and A. P. Fraise. 1999. Mycobactericidal activity of selected disinfectants using a quantitative suspension test. J. Hosp. Infect. 41:111-121.
14. Heersma, H. F., K. Kremer, and J. D. van Embden. 1998. Computer analysis of IS6110 RFLP patterns of Mycobacterium tuberculosis. Methods Mol. Biol. 101:395-422.
15. Johnson, K. R., C. R. Braden, K. L. Cairns, K. W. Field, A. C. Colombel, Z. Yang, C. L. Woodley, G. P. Morlock, A. M. Weber, A. Y. Boudreau, T. A. Bell, I. M. Onorato, S. E. Valway, and P. A. Stehr-Green. 2000. Transmission of Mycobacterium tuberculosis from medical waste. JAMA 284:1683-1688.
16. Kelly, P. 1999. Isolation and stigma: The experience of patients with active tuberculosis. J. Community Health Nurs. 16:233-241.
17. Loenen, A. C. 2001. Farmacotherapeutisch Kompas 2002. College voor Zorgverzekeringen, Amstelveen, The Netherlands.
18. Nitta, A. T., P. T. Davidson, M. L. de Koning, and R. J. Kilman. 1996. Misdiagnosis of multidrug-resistant tuberculosis possibly due to laboratory-related errors. JAMA
19. Ormerod, L. P., and N. Horsfield. 1996. Frequency and type of reactions to antituberculosis drugs: Observations in routine treatment. Tuber. Lung Dis. 77:37-42.
20. Royal Netherlands Tuberculosis Association. 1999. Index Tuberculosis 1997. Royal Netherlands Tuberculosis Association, The Hague, The Netherlands.
21. Segal-Maurer, S., B. N. Kreiswirth, J. M. Burns, S. Lavie, M. Lim, C. Urban, and J. J. Rahal, Jr. 1998. Mycobacterium tuberculosis specimen contamination revisited: The role of laboratory environmental control in a pseudo-outbreak. Infect. Control Hosp. Epidemiol. 19:101-105.
22. Small, P. M., N. B. McClenny, S. P. Singh, G. K. Schoolnik, L. S. Tompkins, and P. A. Mickelsen. 1993. Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures. J. Clin. Microbiol. 31:1677-1682.
23. Van Duin, J. M., J. E. Pijnenburg, C. M. van Rijswoud, P. E. de Haas, W. D. Hendriks, and D. van Soolingen. 1998. Investigation of cross contamination in a Mycobacterium tuberculosis laboratory using IS6110 DNA fingerprinting. Int. J. Tuberc. Lung Dis. 2:425-429.
24. van Embden, J. D., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. Gicquel, P. Hermans, C. Martin, R. McAdam, T. M. Shinnick, et al. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: Recommendations for a standardized methodology. J. Clin. Microbiol. 31:406-409.
25. van Soolingen, D. 1998. Utility of molecular epidemiology of tuberculosis. Eur. Respir. J 11:795-797.
26. Wurtz, R., P. Demarais, W. Trainor, J. McAuley, F. Kocka, L. Mosher, and S. Dietrich. 1996. Specimen contamination in mycobacteriology laboratory detected by pseudo-outbreak of multidrug-resistant tuberculosis: Analysis by routine epidemiology and confirmation by molecular technique. J. Clin. Microbiol. 34:1017-1019.
27. Wurtz, R., J, Fernandez, and B. Jovanovic. 1994. Real and apparent tuberculin skin test conversions in a group of medical students. Infect. Control Hosp. Epidemiol. 15:516-519.